Active, not recruitingPhase 3NCT05329090
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
Studying Immunoglobulin A vasculitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hopital Foch
- Principal Investigator
- Romain Paule, DrHôpital Foch
- Intervention
- Rituximab Injection(drug)
- Enrollment
- 75 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2026
Study locations (13)
- Hopital La Cavale Blanche, Brest, France
- CHU Clermont Ferrand, Clermont-Ferrand, France
- Hôpital Edouard Herriot, Lyon, France
- CHU Marseille, Marseille, France
- APHM de La Timone, Marseille, France
- Hôpital André Grégoire, Montreuil, France
- CHU Nantes, Nantes, France
- CHU Nîmes (Caremeau), Nîmes, France
- Hôpital Cochin, Paris, France
- CHU Strasbourg, Strasbourg, France
- Hôpital Foch, Suresnes, France
- CHU Toulouse, Toulouse, France
- CHRU Bretonneau, Tours, France
Collaborators
Ministry of Health, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05329090 on ClinicalTrials.govOther trials for Immunoglobulin A vasculitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07315191Finerenone Therapy for Pediatric HSPN With Mild ProteinuriaCapital Institute of Pediatrics, China
- RECRUITINGNANCT05951517Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein PurpuraSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- RECRUITINGNANCT03647852Clinical Study on Strategy for Refractory Henoch-Schönlein PurpuraChildren's Hospital of Fudan University